Additional file 1. Figure S1. MPL W515L induces megakaryocyte hyperproliferation in vitro and causes myeloproliferative neoplasm in vivo. Figure S2. Cell proliferation and signaling in G1ME cells transduced with various MPL mutants in the presence of TPO. Figure S3. The effect of STAT3-deficiency on megakaryopoiesis. Figure S4. The effect of STAT3 ectopic expression on the megakaryopoiesis. Figure S5. Flow cytometry analysis of BM cells from the recipient mice. Figure S6. Inactivating specific signaling pathway was not enough to suppress hyperproliferation induced by MPL W515L
Additional file 1: Figure S1. Wild and mutant CD59-expressing Jurkat cells were successfully constru...
sis (PMF) are two myeloproliferative diseases characterized by a marked megakaryocytic (MK) involvem...
Additional file 1: Figure S1. Bortezomib-mediated induction of early (Annexin +ive and PI −ive cells...
Thrombopoietin (THPO) and its receptor myeloproliferative leukemia virus oncogene (MPL) regulate hem...
Thrombopoietin (TPO) acting via its receptor, the cellular homologue of the myeloproliferative leuke...
Constitutively active JAK2V617F and thrombopoietin receptor (TpoR) W515L/K mutants are major determi...
Additional file 3: Figure S3. Expression of α2-AR on mouse MDSC. LLC cells were injected s.c. into t...
Dnm2fl/fl Pf4-Cre (Dnm2Plt–/–) mice lacking the endocytic GTPase dynamin 2 (DNM2) in platelets and m...
Dnm2fl/fl Pf4-Cre (Dnm2Plt–/–) mice lacking the endocytic GTPase dynamin 2 (DNM2) in platelets and m...
Additional file 3: Fig. S3. Cell cycle phase distribution. Representative flow cytometry histograms ...
The acquired somatic JAK2-V617F mutation is present in <80% of patients with myeloproliferative neop...
Multiple myeloma (MM) is a neoplasm of plasma cell origin that is largely confined to the bone marro...
Somatic Nucleophosmin (NPM1) mutation frequently occurs in acute myeloid leukemia (AML), but its rol...
Additional file 1: Figure S1. A. The transfection efficiency of GFP-labelled adenovirus. B. Caspase-...
Myeloproliferative neoplasms (MPNs) are a group of blood cancers which reduce lifespan and quality o...
Additional file 1: Figure S1. Wild and mutant CD59-expressing Jurkat cells were successfully constru...
sis (PMF) are two myeloproliferative diseases characterized by a marked megakaryocytic (MK) involvem...
Additional file 1: Figure S1. Bortezomib-mediated induction of early (Annexin +ive and PI −ive cells...
Thrombopoietin (THPO) and its receptor myeloproliferative leukemia virus oncogene (MPL) regulate hem...
Thrombopoietin (TPO) acting via its receptor, the cellular homologue of the myeloproliferative leuke...
Constitutively active JAK2V617F and thrombopoietin receptor (TpoR) W515L/K mutants are major determi...
Additional file 3: Figure S3. Expression of α2-AR on mouse MDSC. LLC cells were injected s.c. into t...
Dnm2fl/fl Pf4-Cre (Dnm2Plt–/–) mice lacking the endocytic GTPase dynamin 2 (DNM2) in platelets and m...
Dnm2fl/fl Pf4-Cre (Dnm2Plt–/–) mice lacking the endocytic GTPase dynamin 2 (DNM2) in platelets and m...
Additional file 3: Fig. S3. Cell cycle phase distribution. Representative flow cytometry histograms ...
The acquired somatic JAK2-V617F mutation is present in <80% of patients with myeloproliferative neop...
Multiple myeloma (MM) is a neoplasm of plasma cell origin that is largely confined to the bone marro...
Somatic Nucleophosmin (NPM1) mutation frequently occurs in acute myeloid leukemia (AML), but its rol...
Additional file 1: Figure S1. A. The transfection efficiency of GFP-labelled adenovirus. B. Caspase-...
Myeloproliferative neoplasms (MPNs) are a group of blood cancers which reduce lifespan and quality o...
Additional file 1: Figure S1. Wild and mutant CD59-expressing Jurkat cells were successfully constru...
sis (PMF) are two myeloproliferative diseases characterized by a marked megakaryocytic (MK) involvem...
Additional file 1: Figure S1. Bortezomib-mediated induction of early (Annexin +ive and PI −ive cells...